ConductScience.org, home

Paper42226192

Evolution of treatment and oncological outcomes in patients undergoing radical cystectomy: a comparative analysis across two decades at a tertiary center.

Suartz CV and 11 others. BMC Urol, 2026. Cited by 0 papers, by iCite.

Cite this record

ConductScience Library. Evolution of treatment and oncological outcomes in patients undergoing radical cystectomy: a comparative analysis across two decades at a tertiary center. Papers, record 42226192. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/42226192

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Evolution of treatment and oncological outcomes in patients undergoing radical cystectomy: a comparative analysis across two decades at a tertiary center.
PubMed
Journal
BMC Urol
PubMed
Year
2026
PubMed
Publication types
Journal Article, Comparative Study
PubMed
Citations, by iCite
0
iCite
Revised in PubMed
2026-08-13
PubMed

Authors12

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Suartz CVCaio Vinícius
2Azevedo MFDMaria Fernanda Dias
3Brito PHSPedro Henrique Souza
4Setoue DNDDébora Narumi Demitrol
5de Moraes CMTCaio Mazzoneto Teófilo
6Sant'Anna PVHPedro Vasconcelos Henry
7da Silva LGPLuiz Guilherme Pereira
8Schumacher LBLeonam Bringhenti
9Galvez VVSVictor Vion Sant
10Dener MCMaurício Cordeiro
11Nahas WCWilliam Carlos
12Ribeiro-Filho LALeopoldo Alves

Source PubMed

Download CSV of authors

Topics11

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
CystectomyMajor topic
Urinary Bladder NeoplasmsMajor topic
Humans
Male
Female
Retrospective Studies
Aged
Treatment Outcome
Tertiary Care Centers
Middle Aged
Time Factors

Source PubMed

Download CSV of topics

References22

The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.

OrderPMIDTitleJournalYearIn PapersSource
134023169
Robot assisted radical cystectomy with Florence robotic intracorporeal neobladder (FloRIN): Analysis of survival and functional outcomes after first 100 consecutive patients upon accomplishment of phase 3 IDEAL framework.
Eur J Surg Oncol2021https://conductscience.org/library/papers/34023169PubMed
239887896Global comparison of research ethical review protocols: insights from an international research collaborative.BJU Int2025https://conductscience.org/library/papers/39887896PubMed
338917777Early and late post-procedural complications in different orthotopic neobladder surgical approaches: A systematic review.Surg Oncol2024https://conductscience.org/library/papers/38917777PubMed
431277775Delaying Radical Cystectomy After Neoadjuvant Chemotherapy for Muscle-invasive Bladder Cancer is Associated with Adverse Survival Outcomes.Eur Urol Oncol2019https://conductscience.org/library/papers/31277775PubMed
538688207Honing the Hunt: A Comprehensive Review of Cell-free Tumor DNA to Predict Neoadjuvant Therapy Efficacy in Bladder Cancer.Clin Genitourin Cancer2024https://conductscience.org/library/papers/38688207PubMed
641707170Perioperative Enfortumab Vedotin and Pembrolizumab in Bladder Cancer.N Engl J Med2026https://conductscience.org/library/papers/41707170PubMed
738673019Advances in Urinary Diversion: From Cutaneous Ureterostomy to Orthotopic Neobladder Reconstruction-A Comprehensive Review.J Pers Med2024https://conductscience.org/library/papers/38673019PubMed
827053504Neoadjuvant Chemotherapy for Muscle-Invasive Bladder Cancer: A Systematic Review and Two-Step Meta-Analysis.Oncologist2016https://conductscience.org/library/papers/27053504PubMed
930268659Epidemiology of Bladder Cancer: A Systematic Review and Contemporary Update of Risk Factors in 2018.Eur Urol2018https://conductscience.org/library/papers/30268659PubMed
1033201207Bladder Cancer: A Review.JAMA2020https://conductscience.org/library/papers/33201207PubMed
1119142878Mortality increases when radical cystectomy is delayed more than 12 weeks: results from a Surveillance, Epidemiology, and End Results-Medicare analysis.Cancer2009https://conductscience.org/library/papers/19142878PubMed
1240822997Neoadjuvant Immunotherapy in Bladder Cancer: Ushering in a New Era of Treatment-A Systematic Review of Current Evidence.Eur Urol Open Sci2025https://conductscience.org/library/papers/40822997PubMed
1338572751Global cancer statistics 2022: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries.CA Cancer J Clin2024https://conductscience.org/library/papers/38572751PubMed
1432891639Impact of Perioperative Multidisciplinary Rehabilitation Pathway on Early Outcomes after Robot-assisted Radical Cystectomy: A Matched Analysis.Urology2021https://conductscience.org/library/papers/32891639PubMed
1532444265
Negative Predictive Value of Multiparametric Magnetic Resonance Imaging in the Detection of Clinically Significant Prostate Cancer in the Prostate Imaging Reporting and Data System Era: A Systematic Review and Meta-analysis.
Eur Urol2020https://conductscience.org/library/papers/32444265PubMed
1624887047The burden of bladder cancer care: direct and indirect costs.Curr Opin Urol2014https://conductscience.org/library/papers/24887047PubMed
1724189391Guidelines for perioperative care after radical cystectomy for bladder cancer: Enhanced Recovery After Surgery (ERAS(®)) society recommendations.Clin Nutr2013https://conductscience.org/library/papers/24189391PubMed
1832597214Comparing Perioperative Complications Between Laparoscopic and Robotic Radical Cystectomy for Bladder Cancer.J Endourol2020https://conductscience.org/library/papers/32597214PubMed
1939846128Immunotherapy-based neoadjuvant treatment and complication rates after radical cystectomy.BJU Int2025https://conductscience.org/library/papers/39846128PubMed
2038197902The effect of hospital caseload on perioperative mortality, morbidity and costs in bladder cancer patients undergoing radical cystectomy: results of the German nationwide inpatient data.World J Urol2024https://conductscience.org/library/papers/38197902PubMed

See all 22 referencesDownload CSV of references

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Grants
  • Trials
  • Comments and corrections
  • Cited by
  • Genes
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/42226192

GET https://conductscience.org/api/papers/v1/42226192/references?page=2